Open access
Open access
Powered by Google Translator Translator

Arrhythmias/Electrophysiology

M-A | Colchicine for prevention of post-operative atrial fibrillation

27 Jan, 2023 | 12:03h | UTC

Colchicine for prevention of post-operative atrial fibrillation: Meta-analysis of randomized controlled trials – Frontiers in Cardiovascular Medicine

 


RCT | Small study suggests hybrid ablation is more effective than repeated catheter ablation in persistent atrial fibrillation

23 Jan, 2023 | 13:23h | UTC

Hybrid Ablation Versus Repeated Catheter Ablation in Persistent Atrial Fibrillation: A Randomized Controlled Trial – JACC: Clinical Electrophysiology

Commentary: Hybrid Versus Catheter Ablation in Persistent Atrial Fibrillation – HARTCAP-AF – American College of Cardiology

 


EASY-WPW: a novel ECG-algorithm for localization of manifest accessory pathways in children and adults

20 Jan, 2023 | 14:26h | UTC

EASY-WPW: a novel ECG-algorithm for easy and reliable localization of manifest accessory pathways in children and adults – EP Europace

 

Commentary on Twitter

Under a https://creativecommons.org/licenses/by-nc/4.0/ license

 


RCT | In patients with AF undergoing ablation, the addition of posterior wall isolation to pulmonary vein isolation (PVI) was not better than PVI alone

11 Jan, 2023 | 14:33h | UTC

Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Catheter Ablation for Persistent Atrial Fibrillation – JAMA (free for a limited period)

See also: Visual abstract

 


Reviews | Antiarrhythmic drugs and anesthesia

11 Jan, 2023 | 14:06h | UTC

Antiarrhythmic drugs and anaesthesia: part 1. mechanisms of cardiac arrhythmias – BJA Education

Antiarrhythmic drugs and anaesthesia. Part 2: pharmacotherapy – BJA Education

 


M-A | Techniques improving electrical cardioversion success for patients with atrial fibrillation

10 Jan, 2023 | 14:12h | UTC

Techniques improving electrical cardioversion success for patients with atrial fibrillation: a systematic review and meta-analysis – EP Europace

 


The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias

9 Jan, 2023 | 14:19h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias – European Heart Journal

 

Commentary on Twitter

 


The ‘10 commandments’ for the 2022 ESC Guidelines on ventricular arrhythmias and prevention of sudden cardiac death.

9 Dec, 2022 | 13:29h | UTC

The ‘10 commandments’ for the 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The 2022 ESC Guidelines for the management of patients with ventricular arrhythmias (VAs) and the prevention of sudden cardiac death (SCD) present an update of the 2015 guidelines. – European Heart Journal

Original Guideline: #ESCCongress | 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.

 


M-A | Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

9 Dec, 2022 | 13:20h | UTC

Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis – Heart

 


Cohort Study | Poor R-wave progression as a predictor of sudden cardiac death in the general population and subjects with CAD.

8 Dec, 2022 | 12:58h | UTC

Poor R-wave progression as a predictor of sudden cardiac death in the general population and subjects with coronary artery disease – Heart Rhythm

Commentary: Poor R-wave progression is linked to sudden cardiac death: Study – Medical Dialogues

 

Commentary on Twitter

 


Podcast | Atrial fibrillation: rhythm control, catheter ablation, Afib in the hospital, and left atrial appendage closure.

6 Dec, 2022 | 13:42h | UTC

#363 Afib: Rhythm Control, Catheter Ablation, Afib in the hospital, and Left Atrial Appendage Closure – The Curbsiders

 


Monitoring and diagnosis of intermittent arrhythmias: evidence-based guidance and role of novel monitoring strategies.

30 Nov, 2022 | 13:34h | UTC

Monitoring and diagnosis of intermittent arrhythmias: evidence-based guidance and role of novel monitoring strategies – European Heart Journal Openv

 


Review | Obesity as a risk factor for cardiac arrhythmias.

25 Nov, 2022 | 12:21h | UTC

Obesity as a risk factor for cardiac arrhythmias – BMJ Medicine

 

Commentary on Twitter

 


RCT | Subcutaneous vs. transvenous implantable cardioverter defibrillator implantations.

22 Nov, 2022 | 13:19h | UTC

Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations: A Randomized, Multicenter Trial – Annals of Internal Medicine (link to abstract – $ for full-text) 

News Release: S-ICD Associated with 92 Percent Reduction in Lead-Related Complications Typical in Patients with ICDs – American College of Physicians 

Commentaries: 

Subcutaneous ICD Reduces Lead-Related Complications – HealthDay 

Subcutaneous implantable cardioverter defibrillators reduce the risk of perioperative complications – Physician’s Weekly 

Related: 

Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial – European Heart Journal 

Subcutaneous or Transvenous Defibrillator Therapy – New England Journal of Medicine 

 

Commentary on Twitter 

 

 


2ry analysis of a RCT | Device-related complications in subcutaneous versus transvenous ICD.

22 Nov, 2022 | 13:16h | UTC

Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial – European Heart Journal 

Original Study: Subcutaneous or Transvenous Defibrillator Therapy – New England Journal of Medicine 

Related: Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations: A Randomized, Multicenter Trial – Annals of Internal Medicine (link to abstract – $ for full-text) 

 


RCT | A small study tested Apixaban’s efficacy and safety versus a Vitamin K-antagonist in patients on chronic hemodialysis.

11 Nov, 2022 | 13:52h | UTC

A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study – Circulation

Related Study: Apixaban for Patients with Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial – Circulation

 


AHA Scientific Statement | Arrhythmias in repaired Tetralogy of Fallot.

9 Nov, 2022 | 12:33h | UTC

Arrhythmias in Repaired Tetralogy of Fallot: A Scientific Statement From the American Heart Association – Circulation: Arrhythmia and Electrophysiology

Summary: Arrhythmias in Repaired Tetralogy of Fallot – American Heart Association

Top Things to Know: Arrhythmias in Repaired Tetralogy of Fallot – American Heart Association

Commentary: Challenges in Managing Arrhythmias in Adult Tetralogy of Fallot – American Heart Association

 


RCT | In patients with paroxysmal, untreated AF, cryoballoon ablation reduced recurrence compared to drug therapy.

8 Nov, 2022 | 12:29h | UTC

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Review | Oral anticoagulant use in patients with atrial fibrillation and chronic kidney disease.

8 Nov, 2022 | 12:02h | UTC

Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice – Heart Lung and Circulation

 


RCT | Effect of high-intensity interval training in patients with atrial fibrillation.

3 Nov, 2022 | 13:53h | UTC

Effect of High-Intensity Interval Training in Patients With Atrial Fibrillation: A Randomized Clinical Trial – JAMA Network Open

 

Commentary from the author on Twitter (thread – click for more)

Under a CC-BY License License

 


Observational study suggests Apixaban for AF is associated with a lower risk of GI bleeding vs. other DOACs.

3 Nov, 2022 | 13:32h | UTC

Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)

News Release: Best blood thinner for minimizing bleeding risk identified – University College London

Commentary: GI Bleeding Lower With Apixaban Versus Other DOACs in A-Fib – HealthDay

 


M-A | The success rate of cardioversion for AF was similar between anterior-posterior vs. anterior-lateral electrodes position.

1 Nov, 2022 | 12:09h | UTC

Anterior-Posterior versus anterior-lateral electrodes position for electrical cardioversion of atrial fibrillation: A meta-analysis of randomized controlled trials – IJC Heart & Vasculature

 


RCT | Pulmonary vein isolation plus individualized substrate ablation of atrial low-voltage myocardium reduced A-fib recurrence.

28 Oct, 2022 | 13:24h | UTC

Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation – NEJM Evidence

 

Commentary on Twitter

 


Cohort Study | Cannabis, cocaine, methamphetamine, and opiates linked to increased risk of incident atrial fibrillation.

27 Oct, 2022 | 12:29h | UTC

Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation – European Heart Journal

Editorial: Drug abuse and risk of atrial fibrillation: a neglected association – European Heart Journal

Commentaries:

Illicit drugs associated with increased likelihood of developing atrial fibrillation – European Society of Cardiology/News Medical

Marijuana, Meth, Cocaine Use Can Help Trigger Dangerous A-Fib – HealthDay

 

Commentary on Twitter

 


Cohort Study | Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.

24 Oct, 2022 | 14:08h | UTC

Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy – European Heart Journal

Editorial: Arrhythmogenic cardiomyopathies in children: seek and you shall find – European Heart Journal

 

Commentary on Twitter

Under a https://creativecommons.org/licenses/by-nc/4.0/ License

 


Stay Updated in Your Specialty

No spam, just news.